Anna Lisa Iorio

578 citations
15 papers · 441 indexed · h-index 11
Topics
Glioma Diagnosis and Treatment (6 papers)MicroRNA in disease regulation (3 papers)Nanoparticle-Based Drug Delivery (3 papers)
Partner nations
Italy

In The Last Decade

Anna Lisa Iorio

14 papers receiving 436 citations

Peers

Anna Lisa Iorio
Comparison fields: 5 of 67
  • Molecular Biology 175
  • Genetics 128
  • Cancer Research 110
  • Biomedical Engineering 93
  • Oncology 82
Replace Xuhui Yang with:
Xuhui Yang China
Xiaoning Lin China
Fidan Seker-Polat United States
Ştefana Oana Purcaru Romania
Ebrahim Kharazinejad Iran
G. Ian Gallicano United States
Amir Barzegar Behrooz Iran
Céléna Dubuc Canada
Irina Kozhukharova Russia
Markus Fußer Norway
Anna Lisa Iorio relative to Xuhui Yang China Xuhui Yang's profile →
Citations per field
00.5×3.0×
Xuhui Yang · 1×
Citations per year

Countries citing papers authored by Anna Lisa Iorio

Since Specialization
Citations

This map shows the geographic impact of Anna Lisa Iorio's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Anna Lisa Iorio with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Anna Lisa Iorio more than expected).

Fields of papers citing papers by Anna Lisa Iorio

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Anna Lisa Iorio. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Anna Lisa Iorio. The network helps show where Anna Lisa Iorio may publish in the future.

Co-authorship network of co-authors of Anna Lisa Iorio

This figure shows the co-authorship network connecting the top 25 collaborators of Anna Lisa Iorio. A scholar is included among the top collaborators of Anna Lisa Iorio based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Anna Lisa Iorio. Anna Lisa Iorio is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

15 of 15 papers shown
#WorkIndexed citations
1 0
2 21
3 15
4 177
5 16
6 20
7 1
8 30
9 66
10
Morphine modulates doxorubicin uptake and improves efficacy of chemotherapy in an intracranial xenograft model of human glioblastoma.
11
11
Anti-miR21 oligonucleotide enhances chemosensitivity of T98G cell line to doxorubicin by inducing apoptosis.
36
12 21
13 1
14 1
15 25

About Anna Lisa Iorio

Anna Lisa Iorio is a scholar working on Genetics, Cancer Research and Biomaterials, having authored 15 papers that have together received 441 indexed citations. Recurring topics across this work include Glioma Diagnosis and Treatment (6 papers), MicroRNA in disease regulation (3 papers) and Nanoparticle-Based Drug Delivery (3 papers). The work is most often cited by research in Genetics (128 citations), Cancer Research (110 citations) and Reproductive Medicine (61 citations). Anna Lisa Iorio has collaborated with scholars based in Italy. Frequent co-authors include Iacopo Sardi, Martina Da Ros, Maurizio de Martino, Lorenzo Genitori, Laura Giunti, Milena Guidi, Veronica De Gregorio, M Lucchesi, Ornella Fantappiè and Claudio Pisano. Their work appears in journals such as International Journal of Molecular Sciences, Cancer Letters and Medicine.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026